Henk W. Berendse

Henk W. Berendse's AcademicInfluence.com Rankings

Henk W. Berendse

Biology

#12784

World Rank

#16283

Historical Rank

Neuroscience

#2168

World Rank

#2229

Historical Rank

biology Degrees

Download Badge

Biology

Henk W. Berendse's Degrees

Doctorate Medicine University of Amsterdam

Why Is Henk W. Berendse Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Henk W. Berendse's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. (2009) (845)
Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat (1992) (834)
Idiopathic hyposmia as a preclinical sign of Parkinson's disease (2004) (717)
Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum (1990) (569)
The specificity of the ‘nonspecific’ midline and intralaminar thalamic nuclei (1994) (528)
The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization. (1990) (525)
Restricted cortical termination fields of the midline and intralaminar thalamic nuclei in the rat (1991) (501)
The application of graph theoretical analysis to complex networks in the brain (2007) (481)
Organization of the output of the ventral striatopallidal system in the rat: Ventral pallidal efferents (1993) (433)
Frequency-dependent functional connectivity within resting-state networks: An atlas-based MEG beamformer solution (2012) (369)
Prevalence of smell loss in Parkinson's disease--a multicenter study. (2009) (344)
Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease (2006) (304)
Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat (1990) (301)
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell (2001) (292)
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease (2017) (278)
A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease (2011) (278)
Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis (2001) (264)
Generalized Synchronization of MEG Recordings in Alzheimer’s Disease: Evidence for Involvement of the Gamma Band (2002) (257)
Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. (2007) (245)
Disrupted brain network topology in Parkinson's disease: a longitudinal magnetoencephalography study. (2014) (214)
Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: An MEG study (2008) (184)
Genome-wide association study confirms extant PD risk loci among the Dutch (2011) (175)
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease (2016) (174)
Resting state oscillatory brain dynamics in Parkinson’s disease: An MEG study (2006) (163)
Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study (2000) (154)
[Impulse control disorders in Parkinson's disease]. (2011) (151)
Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial (2010) (147)
Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study (2013) (132)
Functional connectivity and cognitive decline over 3 years in Parkinson disease (2014) (127)
Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study (2009) (125)
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus (2013) (117)
The effect of rhythmic somatosensory cueing on gait in patients with Parkinson's disease (2006) (115)
A comparative study of odor identification and odor discrimination deficits in Parkinson's disease (2008) (113)
Stage‐dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease (2014) (112)
Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume (2015) (107)
Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease (2009) (106)
Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease (2011) (105)
Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease (2014) (99)
Distribution and Load of Amyloid-&bgr; Pathology in Parkinson Disease and Dementia with Lewy Bodies (2016) (97)
Frontal–striatal abnormalities underlying behaviours in the compulsive–impulsive spectrum (2010) (94)
Anatomical Relationships Between the Prefrontal Cortex and the Basal Ganglia in the Rat (1994) (89)
The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study (2011) (87)
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease (2012) (87)
Depression and impulse control disorders in Parkinson's disease: Two sides of the same coin? (2014) (86)
Preclinical (premotor) Parkinson’s disease (2000) (85)
Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing (2017) (85)
Nuclear origin of thalamic afferents of the ventral striatum determines their relation to patch/matrix configurations in enkephalin-immunoreactivity in the rat. (1988) (83)
MEG resting state functional connectivity in Parkinson’s disease related dementia (2009) (83)
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease (2013) (82)
CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease. (2010) (81)
Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease (2016) (79)
Densitometrical analysis of opioid receptor ligand binding in the human striatum—I. Distribution of μ opioid receptor defines shell and core of the ventral striatum (1996) (77)
Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers (2014) (72)
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data (2016) (71)
The effects of visual rhythms and optic flow on stride patterns of patients with Parkinson's disease. (2006) (71)
Effects of augmented visual feedback during balance training in Parkinson's disease: a pilot randomized clinical trial. (2014) (70)
Reduced α‐synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity (2014) (69)
Detection of preclinical Parkinson's disease along the olfactory trac(t). (2006) (67)
Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging. (2009) (67)
A neural complexity measure applied to MEG data in Alzheimer's disease (2003) (66)
Evidence For Two Neurochemical Divisions in the Human Nucleus Accumbens (1994) (66)
Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach (2010) (66)
Resting-state functional connectivity as a marker of disease progression in Parkinson's disease: A longitudinal MEG study☆ (2013) (65)
Dopaminergic modulation of cortico-cortical functional connectivity in Parkinson's disease: An MEG study (2008) (64)
Localization of Slow Wave Activity in Patients with Tumor-Associated Epilepsy (2004) (62)
α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies (2018) (61)
Anxiety in Parkinson's disease: Symptom dimensions and overlap with depression and autonomic failure. (2015) (58)
A smaller amygdala is associated with anxiety in Parkinson’s disease: a combined FreeSurfer—VBM study (2015) (58)
Interventions for fatigue in Parkinson's disease. (2015) (58)
Reduced neural connectivity but increased task‐related activity during working memory in de novo Parkinson patients (2015) (58)
The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis (2012) (57)
Impairment of complex upper limb motor function in de novo Parkinson's disease. (2008) (57)
Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? (2008) (57)
CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls (2019) (54)
The Connections of the Medial Part of the Subthalamic Nucleus in the Rat: Evidence for a Parallel Organization (1991) (53)
Method to measure autonomic control of cardiac function using time interval parameters from impedance cardiography (2008) (52)
Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence (2012) (52)
Motor perseveration is an early sign of Parkinson’s disease (2001) (49)
Signal-to-noise ratio of chemosensory event-related potentials (2007) (48)
Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson’s Disease (2016) (46)
Compensatory fronto-parietal hyperactivation during set-shifting in unmedicated patients with Parkinson's disease (2015) (46)
Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease (2016) (44)
Pneumocephalus by Valsalva’s maneuver (2003) (42)
Bimanual coordination dysfunction in early, untreated Parkinson's disease. (2006) (42)
A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamforming☆ (2012) (41)
Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson’s disease related dementia (2008) (41)
Stage-dependent patterns of disturbed neural synchrony in Parkinson's disease. (2007) (41)
Increased Resting-State Functional Connectivity in Obese Adolescents; A Magnetoencephalographic Pilot Study (2008) (40)
Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients. (2013) (38)
Failure of stop and go in de novo Parkinson's disease—a functional magnetic resonance imaging study (2015) (38)
Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease. (2012) (36)
Loss of Functional Connectivity in Patients with Parkinson Disease and Visual Hallucinations. (2017) (36)
A systematic review of MEG‐based studies in Parkinson's disease: The motor system and beyond (2019) (35)
Impaired planning in Parkinson's disease is reflected by reduced brain activation and connectivity (2015) (34)
Organization of the Projections from the Ventral Striato-Pallidal System to Ventral Mesencephalic Dopaminergic Neurons in the Rat (1994) (34)
The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease. (2017) (34)
Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease (2019) (33)
Odour identification and discrimination in Dutch adults over 45 years. (2008) (33)
Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients. (2013) (33)
Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases (2017) (33)
Beneficial effect of transcranial magnetic stimulation on sleep in Parkinson's disease (2009) (33)
Quantification of dopamine transporter binding using [18F]FP-β-CIT and positron emission tomography (2006) (33)
International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease (2021) (33)
Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum (1993) (32)
Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: Results from a pilot randomized controlled trial. (2017) (31)
Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned (2016) (31)
Extended testing across, not within, tasks raises diagnostic accuracy of smell testing in Parkinson's disease (2009) (31)
A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands (2020) (31)
Serotonin transporter binding and anxiety symptoms in Parkinson’s disease (2017) (31)
Bright light therapy for depression in Parkinson disease (2019) (30)
Slowing of M1 activity in Parkinson’s disease during rest and movement – An MEG study (2011) (30)
Early-stage [123I]β-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson’s disease (2005) (30)
Management of psychosis in Parkinson's disease (2001) (30)
Deficits on Corsi's block-tapping task in early stage Parkinson's disease. (2003) (29)
Early‐stage cognitive impairment in Parkinson’s disease and the influence of dopamine replacement therapy (2012) (29)
The Effects of Cognitive Training on Brain Network Activity and Connectivity in Aging and Neurodegenerative Diseases: a Systematic Review (2020) (28)
Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease. (2013) (27)
Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study. (2017) (26)
Changes in resting-state directed connectivity in cortico-subcortical networks correlate with cognitive function in Parkinson’s disease (2017) (26)
Complexity Analysis of Resting-State MEG Activity in Early-Stage Parkinson’s Disease Patients (2011) (24)
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD (2015) (24)
Early-onset cortico-cortical synchronization in the hemiparkinsonian rat model. (2015) (24)
Anxiety in Parkinson's disease is associated with reduced structural covariance of the striatum. (2018) (23)
Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder (2018) (23)
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers (2020) (22)
Global and Subnetwork Changes of the Structural Connectome in de novo Parkinson’s Disease (2018) (22)
Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series (2020) (22)
Abnormal susceptibility to distracters hinders perception in early stage Parkinson's disease: a controlled study (2006) (21)
The Dopamine Stabilizer (−)-OSU6162 Occupies a Subpopulation of Striatal Dopamine D2/D3 Receptors: An [11C]Raclopride PET Study in Healthy Human Subjects (2015) (21)
Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson’s disease patients with visual hallucinations (2017) (21)
[Presymptomatic detection of Parkinson's disease]. (2002) (21)
Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis (2019) (21)
The Basal Ganglia IX (2009) (21)
Treatment of Fatigue in Parkinson Disease. (2016) (21)
Novelty processing and memory formation in Parkinson׳s disease (2014) (20)
Using PROMs during routine medical consultations: The perspectives of people with Parkinson’s disease and their health professionals (2019) (19)
Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study (2019) (18)
Alterations in Functional Cortical Hierarchy in Hemiparkinsonian Rats (2017) (17)
Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies (2016) (16)
A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson’s disease (2016) (16)
Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies (2020) (16)
Profiling cognitive and neuropsychiatric heterogeneity in Parkinson's disease. (2016) (16)
Opioid receptor ligand binding in the human striatum: II. Heterogeneous distribution of kappa opioid receptor labeled with [3H]Bremazocine (1996) (15)
Flavor perception and the risk of malnutrition in patients with Parkinson’s disease (2018) (15)
Advanced time‐series analysis of MEG data as a method to explore olfactory function in healthy controls and Parkinson's disease patients (2009) (15)
Differences in neurology residency training programmes across Europe – a survey among the Residents and Research Fellow Section of the European Academy of Neurology national representatives (2020) (15)
The ParkinsonNet trial: Design and baseline characteristics (2010) (15)
Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies (2018) (15)
Parkinsonism & related disorders. Proceedings of the XVII WFN World Congress on Parkinson's disease and related disorders. (2007) (14)
Anterior insular network disconnection and cognitive impairment in Parkinson’s disease (2020) (13)
The Association of Olfactory Function with BMI, Appetite, and Prospective Weight Change in Dutch Community-Dwelling Older Adults (2019) (13)
Motor effects of deep brain stimulation correlate with increased functional connectivity in Parkinson's disease: An MEG study (2020) (11)
SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias (2013) (11)
Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway (2011) (11)
Diplopia in Parkinson’s disease: visual illusion or oculomotor impairment? (2019) (10)
Odor recognition memory is not independently impaired in Parkinson’s disease (2009) (10)
In vivo exploration of retinal nerve fiber layer morphology in Parkinson’s disease patients (2018) (10)
Functional connectivity between resting-state networks reflects decline in executive function in Parkinson’s disease: A longitudinal fMRI study (2020) (10)
Processing speed is related to striatal dopamine transporter availability in Parkinson's disease (2020) (10)
The influence of computer experience on visuo-motor control: implications for visuo-motor testing in Parkinson’s disease (2002) (10)
Gray matter differences contribute to variation in cognitive performance in Parkinson's disease (2014) (9)
Using time interval parameters from impedance cardiography to evaluate autonomic nervous function in Parkinson’s disease (2007) (9)
Reduced task-related functional connectivity during a set-shifting task in unmedicated early-stage Parkinson’s disease patients (2016) (9)
Using the Initial Systolic Time Interval to assess cardiac autonomic nervous function in Parkinson’s disease (2011) (8)
Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies (2020) (8)
COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson’s disease (2019) (8)
Using genome-Wwide complex trait analysis to quantify 'missing heritability' in Parkinson's disease (2012) (8)
Disrupted Brain Network Topology in Parkinson's Disease: a Longitudinal Meg Study (2014) (8)
A 51‐year‐old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment (2009) (8)
CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease (2020) (8)
Structural and functional correlates of subthalamic deep brain stimulation-induced apathy in Parkinson’s disease (2020) (7)
BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson’s disease: study protocol for a randomized controlled trial (2015) (6)
[Parkinson's disease: pathogenesis, aetiology, symptoms, diagnostics, and its course]. (2018) (6)
Structural network topology and microstructural alterations of the anterior insula associate with cognitive and affective impairment in Parkinson’s disease (2021) (6)
Differences in neurology residency training programmes across Europe - a survey among EAN-RRFS national representatives. (2020) (6)
Serotonin Transporter Availability in Early Stage Parkinson's Disease and Multiple System Atrophy (2014) (5)
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population (2022) (5)
A smaller amygdala is associated with anxiety in Parkinson’s disease – a combined FreeSurfer-Voxel-based-morphometry study (2015) (5)
Olfactory dysfunction in Parkinson's disease and related disorders (2010) (5)
An International Multicenter Analysis of Brain Structure across Clinical Stages of Parkinson's Disease: The ENIGMA-Parkinson's Study (2020) (5)
CHanGes In endolYsosoMal enzYMe aCtIVItIes In CereBrosPInal (2014) (4)
Observations on the cortical silent period in Parkinson's disease. (2007) (4)
P2.082 ParkNet: a multifaceted strategy to implement practice guidelines for physiotherapy in Parkinson's disease (2007) (4)
Visual hallucinations in Parkinson’s disease are associated with thinning of the inner retina (2020) (4)
[Hypersexuality and other impulse control disorders in Parkinson's disease]. (2016) (4)
Eight-week multi-domain cognitive training does not impact large-scale resting-state brain networks in Parkinson’s disease (2022) (4)
Is dopaminergic medication dose associated with self-reported bruxism in Parkinson’s disease? A cross-sectional, questionnaire-based study (2020) (4)
Salivation in Parkinson's disease: A scoping review. (2022) (4)
Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial. (2022) (4)
Longitudinal consistency of source-space spectral power and functional connectivity using different magnetoencephalography recording systems (2021) (3)
Clinical Applications of [123I]FP-CIT SPECT Imaging (2014) (3)
Optically nonlinear effects in bulk chiral nematic NLO-polymers: second harmonic generation in chiral nematic polymer films (1995) (3)
Erratum to: α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies: CSF α-Synuclein species as biomarkers for DLB (Movement Disorders, (2018), 33, 11, (1724-1733), 10.1002/mds.111) (2019) (3)
I.4 Early diagnosis in PD: olfaction (2006) (3)
Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing (2017) (3)
CSF alpha-synuclein is not diagnostic for dementia with Lewy bodies, but related to cognitive decline (2010) (2)
1.106 Are brain networks changed in Parkinson's disease? A graph theoretical analysis of resting-state magneto-encephalographic functional connectivity (2007) (2)
Balance training with augmented visual feedback in Parkinson’s disease: a randomized clinical trial (2015) (2)
What you always wanted to know about … Early Markers in PD (2007) (2)
PL6.4 Selected oral abstract: ParkNet implementation: evaluation of health bene.ts (2008) (2)
ALPHA-SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIA WITH LEWY BODIES (2017) (2)
Using PROMs during routine medical consultations (2019) (2)
Effect of Eight-Week Online Cognitive Training in Parkinson's Disease: A Randomized Controlled Trial (2021) (2)
Early stage CIT SPECT and long- term clinical follow-up in patients with an initial clinical diagnosis of Parkinson's disease (2004) (2)
Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism (2005) (2)
Parkinsonism & Related Disorders (2008) (2)
Improving the efficiency of physiotherapeutic care in Parkinson's disease: ParkNet trial. (2005) (2)
3.405 ParkNet implementation: Evaluation of health benefits (2007) (1)
P.5.d.005 Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease (2013) (1)
V.9 Cognitive dysfunction and dementia in Parkinson's Disease: EEG/MEG experience (2006) (1)
LOWE 123 IFP-CIT BINDING TO THE STRIA AL DOPAMINE TRANSPORTER , BUT NOT TO TH EXTRASTRIATAL SEROTONIN TRANSPORTER , IN PARKINSON ’ S DISEASE COMPARED WITH DEMENTIA WITH LEWY BODIES 3 (2018) (1)
[Anxiety, depression and sleep disorders in Parkinson's disease: a complex interaction between body and mind]. (2020) (1)
Pathological organization of resting-state functional brain networks in Parkinson's disease: A longitudinal MEG graph theoretical analysis (2013) (1)
Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review (2022) (1)
Cognitive Training in Parkinson’s Disease Induces Local, Not Global, Changes in White Matter Microstructure (2021) (1)
The Effects of Bright Light Therapy on Depression, Sleep and Circadian Rhythm in Patients with Parkinson's Disease and a Depressive Disorder: Results of a Double-Blind Randomized Controlled Trial (2018) (1)
3.016 Dopamine dependent changes in resting-state cortico-cortical synchronisation in mild to moderate Parkinson's disease (2007) (1)
Balance training with augmented visual feedback in Parkinson's disease: a randomized clinical trial (2015) (1)
Functional connectivity alterations in Parkinson’s disease during the stop-signal task (2018) (1)
Neuroimaging in movement disorders: PET and SPECT [ch.32] (2007) (1)
V.10 The neurophysiology of dementia in Parkinson's Disease: does connectivity count? (2006) (1)
[Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide]. (2009) (1)
IV.P12 The influence of dopaminomimetics on resting state functional connectivity in Parkinson's Disease: an MEG study (2006) (1)
Deletions at 22q11.2 in idiopathic Parkinson's disease: A combined analysis of GWAS data (2016) (1)
[Possible treatment options for Parkinson's disease]. (2019) (1)
Detection of preclinical Parkinson's disease: the olfactory approach (2004) (1)
5th International Conference on Neurology and Epidemiology. Gold Coast, Australia, November 18-20, 2015: Abstracts (2015) (1)
Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome (2022) (0)
LONGITUDINAL DECREASES IN FUNCTIONAL CONNECTIVITY AND COGNITIVE DECLINE IN PARKINSON’S DISEASE (2014) (0)
Reply (2005) (0)
Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-centre observational outpatient study (2022) (0)
Chapter 7 Interventions for fatigue in Parkinson ’ s disease : a Cochrane Review (2015) (0)
Corrigendum to “Structural and functional correlates of deep brain stimulation-induced apathy in Parkinson's disease” (2022) (0)
1.111 Impaired odour recognition memory in Parkinson's disease (2007) (0)
Reply: Olfaction and early detection of Parkinson's disease (2005) (0)
PET and SPECT imaging in movement disorders (2006) (0)
An Unusual Dystonic Manifestation in Wilson's Disease (2018) (0)
I.P15 The predictive value of olfactory dysfunction and cognitive dysfunction for preclinical Parkinson's Disease (2006) (0)
IC-P1-015: Random brain networks in Alzheimer's disease (2008) (0)
Distance to white matter tracts predicts STN deep brain stimulation outcome of tremor and dysarthria in Parkinson's disease (2018) (0)
Proteomic Analysis of the Locus Ceruleus in Parkinson's Disease (2010) (0)
The Loss of Extrastriatal As Well As Striatal [I-123]FP-CIT Binding Is More Pronounced in MSA-P and PSP Than in Parkinson's Disease (2016) (0)
Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder (2018) (0)
Cognitive decline relates to reversal of information flow in cortico-subcortical networks in the Parkinson's disease brain (2017) (0)
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease (2016) (0)
The Effects of Cognitive Training on Brain Network Activity and Connectivity in Aging and Neurodegenerative Diseases: a Systematic Review (2020) (0)
2.031 NEUROPHYSIOLOGICAL CORRELATES OF COGNITIVE DECLINE IN PARKINSON'S DISEASE: A LONGITUDINAL MAGNETOENCEPHALOGRAPHIC STUDY (2012) (0)
Chapter 3 Reduced task-related functional connectivity during a set-shifting task in unmedicated Parkinson ’ s disease patients (2015) (0)
Parkinson's disease and oral health: A systematic review. (2023) (0)
Nigral pathology contributes to microstructural integrity of striatal and frontal tracts in Parkinson’s disease (2022) (0)
noVel BIoMarKer CandIdates (2014) (0)
IdentIFICatIon oF noVel BIoMarKer CandIdates In tHe CereBrosPInal FluId ProteoMe oF druG-naïVe ParKInson’s dIsease PatIents (2014) (0)
The neurology of olfaction (2009) (0)
1.112 Olfactory dysfunction in Parkinson's disease: Is extended testing useful to discriminate between patients and controls? (2007) (0)
Proceedings of the XVII WFN World Congress on Parkinson's Disease and Related Disorders, Amsterdam, 9-13 December 2007: Preface (2007) (0)
The confounding effect of computer-experience in the interpretation of computerised visuomotor testing (1999) (0)
Early-stage [I]β-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson’s disease (2005) (0)
Author response for "Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up" (2021) (0)
TV‐L1 Ordinal Logistic Regression Reveals New Morphometric Patterns Related to Parkinsonian Symptom Severity: An ENIGMA‐PD study (2022) (0)
Volume contents (1994) (0)
TUO08 Cholinergic modulation of MEG resting state oscillatory activity in Parkinson's disease related dementia (2008) (0)
1.113 Hyposmia, cognitive dysfunction and the future risk of Parkinson's disease: A five-year prospective study (2007) (0)
2.131 CSF CLUSTERIN IS ASSOCIATED WITH COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE BIOMARKERS IN PARKINSON'S DISEASE PATIENTS (2012) (0)
The effects of dopamine on memory formation in Parkinson's patients (2012) (0)
Reduced task-related functional connectivity during a set-shifting task in unmedicated early-stage Parkinson’s disease patients (2016) (0)
Cortical and Subcortical Changes in MEG Activity Reflect Parkinson's Progression Over a Period of 7 Years (2022) (0)
The article by Ponsen and colleagues 1 and the accompanying editorial by Stern 2 point out the importance of preclinical detection of risk for subsequent development of Parkinson's (2004) (0)
15.18 Improving the efficiency of physiotherapeutic care in Parkinson's disease: the PARKNET trial (2005) (0)
Contents Vol. 45, 2015 (2015) (0)
Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series (2020) (0)
P1-243 ALPHA-SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIAWITH LEWY BODIES (2017) (0)
P2.086 A process evaluation of ParkNet implementation (2007) (0)
3.101 Functional connectivity in Parkinson's disease related dementia: A MEG study (2007) (0)
Olfaction and warly detection of Parkinson's disease. Authors' reply (2005) (0)
Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis (2019) (0)
Nucleus in the Hemiparkinsonian Rat With Deep Brain Stimulation of the Subthalamic The Electrocorticogram Signal Can Be Modulated (2015) (0)
Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson’s disease patients with visual hallucinations (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Henk W. Berendse?

Henk W. Berendse is affiliated with the following schools:

Vrije Universiteit Amsterdam